Moreover, as a critical intracellular kinase within this pathway, tyrosine kinase 2 mediates IL-23 receptor signaling and downstream STAT3 activation, making it a promising therapeutic target for disrupting the IL-23/IL-17-driven inflammatory cascade in psoriasis [40]. Here, TYK2 is linked to psoriasis.